JAMES R III GAVIN
CIK 1220966 · President and CEO · last filed 2020-09-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$909.9K
Companies
3
Total Filings
106
Lifetime Open-Market Net
-$5.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BAX | Director | 43,618 | $20.86 | $909.9K | -$5.10M | 68 | 2020-09-15 |
| Baxalta Inc (BXLT) Delisted | Director | 30,747 | — | — | -$226.2K | 4 | 2016-05-12 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 4,580 | — | — | -$10.0K | 29 | 2012-05-24 |
Recent Filings · Page 9 of 11
106 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-07-09 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-06-10 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-05-07 | BAX | Grant (A) | +1,310 | $0 | EDGAR |
| 2009-04-21 | BAX | Grant (A) | — | $0 | EDGAR |
| 2009-04-07 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-23 | BAX | Grant (A) | — | $0 | EDGAR |
| 2009-01-15 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-10-31 | BAX | Grant (A) | — | $0 | EDGAR |
| 2008-10-06 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-07-25 | BAX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.